Steven Wager
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Pharmacology top 10%
- Treatment of Major Depression
Papers in
-
- Treatment of Major Depression 7
-
- Schizophrenia research and treatment 3
- Electroconvulsive Therapy Studies 2
- Co-authors
- Frederic M. Quitkin (8 shared papers)Edward V. Nunes (5 shared papers)Patrick J. McGrath (6 shared papers)Jonathan W. Stewart (6 shared papers)Wilma M. Harrison (6 shared papers)Donald F. Klein (3 shared papers)Patrick J. McGrath (2 shared papers)Katja Ocepek‐Welikson (4 shared papers)
- Journals
- Journal of Clinical Psychopharmacology (3 papers)American Journal of Psychiatry (1 paper)Drug and Alcohol Dependence (1 paper)Human Psychopharmacology Clinical and Experimental (1 paper)Psychopharmacology Bulletin (1 paper)
- Partner nations
- United StatesArmenia
In The Last Decade
Steven Wager
11 papers receiving 310 citations
Peers
Comparison fields: 5 of 43
- Biological Psychiatry 37
- Pharmacology 153
- Psychiatry and Mental health 131
- Behavioral Neuroscience 21
- Cellular and Molecular Neuroscience 87
Countries citing papers authored by Steven Wager
This map shows the geographic impact of Steven Wager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Wager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Wager more than expected).
Fields of papers citing papers by Steven Wager
This network shows the impact of papers produced by Steven Wager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Wager. The network helps show where Steven Wager may publish in the future.
Co-authors
The 19 scholars most cited alongside Steven Wager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 84 | |
| 2 | 1990 | 59 | |
| 3 | 1992 | 55 | |
| 4 | A placebo-controlled trial of L-deprenyl in atypical depression. | 1989 | 36 |
| 5 | 1990 | 32 | |
| 6 | Phenelzine treatment of melancholia. | 1986 | 29 |
| 7 | 1994 | 19 | |
| 8 | 1993 | 17 | |
| 9 | 1990 | 12 | |
| 10 | 1988 | 1 | |
| 11 | 1995 | 1 |
About Steven Wager
Steven Wager is a scholar working on Pharmacology, Psychiatry and Mental health, Biological Psychiatry, Experimental and Cognitive Psychology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 345 indexed citations. Recurring topics across this work include Treatment of Major Depression (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Schizophrenia research and treatment (3 papers), Tryptophan and brain disorders (2 papers), Electroconvulsive Therapy Studies (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Forensic Toxicology and Drug Analysis (1 paper). The work is most often cited by research in Biological Psychiatry (37 citations), Pharmacology (153 citations), Psychiatry and Mental health (131 citations), Behavioral Neuroscience (21 citations) and Cellular and Molecular Neuroscience (87 citations). Steven Wager has collaborated with scholars based in United States and Armenia. Frequent co-authors include Frederic M. Quitkin, Edward V. Nunes, Patrick J. McGrath, Jonathan W. Stewart, Wilma M. Harrison, Donald F. Klein, Patrick J. McGrath, Katja Ocepek‐Welikson, Frederic M. Quitkin and ELAINE TRICAMO. Their work appears in journals such as Journal of Clinical Psychopharmacology, American Journal of Psychiatry, Drug and Alcohol Dependence, Human Psychopharmacology Clinical and Experimental and Psychopharmacology Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.